Elekta is an international medical-technology Group, providing meaningful
clinical solutions, comprehensive information systems and services for
improved cancer care and management of brain disorders. All of Elekta's
solutions employ non-invasive or minimally invasive techniques and are
therefore clinically effective, gentle on the patient and cost-effective.
Clinical solutions include among others Leksell Gamma Knife(R) for
non-invasive treatment of brain disorders and Elekta Synergy(R) for image
guided radiation therapy (IGRT).
Elekta's systems and solutions are used at over 3,000 hospitals around
the world to treat cancer and manage clinical operations as well as to
diagnose and treat brain disorders, including tumours, vascular
malformations and functional disorders.
With approx. 1850 employees, Elekta's corporate headquarters is located
in Stockholm, Sweden and the company is listed on the Stockholm Stock
Exchange under the ticker EKTAb.